Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:22 am Purchase |
2024-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
FMR CORP | 21,811,697 12.800% |
2,423,118 (+12.50%) |
Filing History |
| 2024-10-02 08:15 am Purchase |
2024-09-30 | 13D | Seres Therapeutics, Inc. MCRB |
NESTLE SA | 21,781,753 14.290% |
21,781,753 (New Position) |
Filing History |
| 2024-04-05 12:21 pm Sale |
2024-03-31 | 13G | Seres Therapeutics, Inc. MCRB |
BLACKROCK INC BLK |
6,825,399 4.500% |
-514,055 (-7.00%) |
Filing History |
| 2024-02-12 12:23 pm Sale |
2023-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
JANUS HENDERSON GROUP PLC JHG |
483 0.000% |
-11,247,809 (-100.00%) |
Filing History |
| 2024-02-09 09:49 am Purchase |
2024-02-08 | 13G | Seres Therapeutics, Inc. MCRB |
FMR CORP | 19,388,579 14.999% |
699,818 (+3.74%) |
Filing History |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
BLACKROCK INC BLK |
7,339,454 5.700% |
1,090,368 (+17.45%) |
Filing History |
| 2023-11-07 12:57 pm Sale |
2023-10-31 | 13G | Seres Therapeutics, Inc. MCRB |
FEDERATED HERMES INC. FHI |
5,175,805 4.040% |
-6,324,715 (-55.00%) |
Filing History |
| 2023-05-10 10:16 am Sale |
2023-04-30 | 13G | Seres Therapeutics, Inc. MCRB |
FEDERATED HERMES INC. FHI |
11,500,520 9.000% |
-6,585,418 (-36.41%) |
Filing History |
| 2023-04-06 09:29 am Sale |
2023-03-31 | 13G | Seres Therapeutics, Inc. MCRB |
BLACKROCK INC BLK |
6,249,086 5.000% |
-209,888 (-3.25%) |
Filing History |
| 2023-02-10 11:46 am Purchase |
2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
JANUS HENDERSON GROUP PLC JHG |
11,248,292 9.000% |
6,193,193 (+122.51%) |
Filing History |
| 2023-02-09 12:31 pm Purchase |
2023-02-09 | 13G | Seres Therapeutics, Inc. MCRB |
FMR CORP | 18,688,761 14.999% |
4,911,691 (+35.65%) |
Filing History |
| 2023-02-09 11:32 am Purchase |
2022-12-30 | 13G | Seres Therapeutics, Inc. MCRB |
The Vanguard Group | 6,092,937 4.890% |
1,416,672 (+30.29%) |
Filing History |
| 2023-02-03 3:19 pm Sale |
2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
STATE STREET CORP STT |
4,564,139 3.660% |
-221,450 (-4.63%) |
Filing History |
| 2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
BLACKROCK INC BLK |
6,458,974 5.200% |
584,616 (+9.95%) |
Filing History |
| 2023-02-01 12:15 pm Purchase |
2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
FEDERATED HERMES INC. FHI |
18,085,938 14.520% |
103,682 (+0.58%) |
Filing History |
| 2022-08-09 4:02 pm Purchase |
2022-07-31 | 13G | Seres Therapeutics, Inc. MCRB |
BLACKROCK INC BLK |
5,874,358 4.700% |
11,667 (+0.20%) |
Filing History |
| 2022-07-22 1:34 pm Sale |
2022-07-18 | 13D | Seres Therapeutics, Inc. MCRB |
Nestle Health Science US Holdings Inc. | 7,594,038 6.100% |
-298,852 (-3.79%) |
Filing History |
| 2022-07-11 2:13 pm Purchase |
2022-06-30 | 13G | Seres Therapeutics, Inc. MCRB |
FEDERATED HERMES INC. FHI |
17,982,256 14.500% |
11,068,120 (+160.08%) |
Filing History |
| 2022-07-07 5:00 pm Purchase |
2022-07-05 | 13D | Seres Therapeutics, Inc. MCRB |
Flagship VentureLabs IV LLC | 23,493,063 18.900% |
8,443,072 (+56.10%) |
Filing History |
| 2022-02-14 4:11 pm Sale |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
RA Capital Management, L.P. | 0 0.000% |
-4,702,206 (Position Closed) |
Filing History |